Novel HSPA8-NR4A2 rearrangement in extraskeletal myxoid chondrosarcoma: a sarcoma mimicker of neuroendocrine neoplasia.

No abstract is available for this paper.

• Publication year

  2025

• Venue

  Virchows Archiv

• Publication date

  2025-11-28

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s00428-025-04352-7PMID 41315062
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• RBMS1-HSPA8 axis activation drives head and neck squamous cell carcinoma progression

  2025cited by this paper
• Sphingolipid and ceramide associations with tau pathology vary across diverse ethnoracial groups in postmortem brain tissue

  2025cited by this paper
• JAK2 46/1 (GGCC) Haplotype in Oncogenesis, as Risk Stratifier, and Indicator for Drug Resistance in Myeloproliferative Neoplasms

  2025cited by this paper
• In Vivo Versus In Vitro Somatostatin Receptor Expression in Neuroendocrine Neoplasms: A Systematic Review and Meta-Analysis of Correlation Studies

  2025cited by this paper
• Advancing sarcoma diagnostics with expanded DNA methylation-based classification

  2025cited by this paper
• HSPA8 and HSPA9: Two prognostic and therapeutic targets in breast, colon, and kidney cancers?

  2025cited by this paper
• Integrated mutational landscape analysis of poorly differentiated high-grade neuroendocrine carcinoma of the uterine cervix

  2024cited by this paper
• HER2 mutations in advanced cervical neuroendocrine carcinoma: implications for trastuzumab deruxtecan therapy

  2024cited by this paper
• Evaluating cell culture reliability in pediatric brain tumor primary cells through DNA methylation profiling

  2024cited by this paper
• Identification of Novel/Rare EWSR1 Fusion Partners in Undifferentiated Mesenchymal Neoplasms

  2024cited by this paper
• Genetic insights into thymic carcinomas and thymic neuroendocrine neoplasms denote prognosis signatures and pathways

  2023cited by this paper
• Genomic characterization reveals distinct mutation landscapes and therapeutic implications in neuroendocrine carcinomas of the gastrointestinal tract

  2022cited by this paper
• A Computational Framework for Comprehensive Genomic Profiling in Solid Cancers: The Analytical Performance of a High-Throughput Assay for Small and Copy Number Variants

  2022cited by this paper
• Extraskeletal myxoid chondrosarcoma: p53 and Ki-67 offer prognostic value for clinical outcome — an immunohistochemical and molecular analysis of 31 cases

  2022cited by this paper
• Integrating a Comprehensive Cancer Genome Profiling into Clinical Practice: A Blueprint in an Italian Referral Center

  2022cited by this paper
• Germline mutations in RAD51C and RAD51D and hereditary predisposition to ovarian cancer.

  2021cited by this paper
• A decade of RAD51C and RAD51D germline variants in cancer

  2021cited by this paper
• Mesenchymal/non-epithelial mimickers of neuroendocrine neoplasms with a focus on fusion gene-associated and SWI/SNF-deficient tumors

  2021cited by this paper
• Unraveling Neuroendocrine Gallbladder Cancer: Comprehensive Clinicopathologic and Molecular Characterization

  2021cited by this paper
• Extraskeletal Myxoid Chondrosarcoma: State of the Art and Current Research on Biology and Clinical Management

  2020cited by this paper
• DNA Methylation Profiling for Diagnosing Undifferentiated Sarcoma with Capicua Transcriptional Receptor (CIC) Alterations

  2020cited by this paper
• PlGF Immunological Impact during Pregnancy

  2020cited by this paper
• A common classification framework for neuroendocrine neoplasms: an International Agency for Research on Cancer (IARC) and World Health Organization (WHO) expert consensus proposal

  2018cited by this paper
• INSM1 expression and its diagnostic significance in extraskeletal myxoid chondrosarcoma

  2018cited by this paper
• fastp: an ultra-fast all-in-one FASTQ preprocessor

  2018cited by this paper
• A precision oncology approach to the pharmacological targeting of mechanistic dependencies in neuroendocrine tumors

  2018cited by this paper
• HSPA8 as a novel fusion partner of NR4A3 in extraskeletal myxoid chondrosarcoma

  2017cited by this paper
• Whole-genome landscape of pancreatic neuroendocrine tumours

  2017cited by this paper
• Extraskeletal myxoid chondrosarcoma with non-EWSR1-NR4A3 variant fusions correlate with rhabdoid phenotype and high-grade morphology.

  2014cited by this paper
• Current understanding of the molecular biology of pancreatic neuroendocrine tumors.

  2013cited by this paper
• Cytopathology of extraskeletal myxoid chondrosarcoma

  2007cited by this paper
• Processing tissue and cells for transmission electron microscopy in diagnostic pathology and research

  2007cited by this paper
• Somatostatin receptor type 2A immunohistochemistry in neuroendocrine tumors: a proposal of scoring system correlated with somatostatin receptor scintigraphy

  2007cited by this paper
• Studies on the molecular pathogenesis of extraskeletal myxoid chondrosarcoma-cytogenetic, molecular genetic, and cDNA microarray analyses.

  2003cited by this paper
• Extraskeletal myxoid chondrosarcoma: a light microscopic, immunohistochemical, ultrastructural and immuno‐ultrastructural study indicating neuroendocrine differentiation

  2001cited by this paper
• Extraskeletal myxoid chondrosarcoma: a clinicopathologic, immunohistochemical, and molecular analysis of 18 cases.

  2001cited by this paper
• Extraskeletal myxoid chondrosarcoma with neuroendocrine differentiation: a pathologic, cytogenetic, and molecular study of a case with a novel translocation t(9;17)(q22;q11.2).

  2000cited by this paper
• Extraskeletal Myxoid Chondrosarcoma: A Clinicopathologic, Immunohistochemical, and Ploidy Analysis of 23 Cases

  2000cited by this paper
• The diffuse endocrine-paracrine system of the gut in health and disease: ultrastructural features.

  1981cited by this paper
• Identification, ultrastructure and classification of gut endocrine cells and related growths.

  1980cited by this paper
• Endocrine cells of the gastrointestinal tract and related tumors.

  1979cited by this paper

• No citing papers are available for this paper.